27 Recruiting Pancreatic Ductal Adenocarcinoma (PDAC) Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Related Conditions
Top Recruiting Pancreatic Ductal Adenocarcinoma (PDAC) Studies
Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life
📍 BC Cancer — Vancouver, British Columbia
View Study & Checklist ➔PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)
📍 University of Vermont Medical Center — Burlington, Vermont
View Study & Checklist ➔ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)
📍 O'Neal Comprehensive Cancer Center, University of Alabama — Birmingham, Alabama
View Study & Checklist ➔Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
📍 University of California, San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
📍 START- Los Angeles — Los Angeles, California
View Study & Checklist ➔Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
📍 University of Colorado Cancer Center — Aurora, Colorado
View Study & Checklist ➔Nutrition Intervention for Pancreatic Cancer
📍 Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔EUS-RFA PANCARDINAL-1 Trial
📍 Memorial Hermann Hospital — Houston, Texas
View Study & Checklist ➔Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
📍 University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Helios CR Inc./RadNet — Cerritos, California
View Study & Checklist ➔A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔